CORRECTION article

Front. Genet., 24 August 2022

Sec. Human and Medical Genomics

Volume 13 - 2022 | https://doi.org/10.3389/fgene.2022.978493

Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer

  • MZ

    Mengjun Zhang 1

  • YL

    Yunduo Liu 1

  • YL

    Yuan Liu 1

  • SH

    Siyu Hou 2

  • HL

    Hao Li 1

  • YM

    Ying Ma 1

  • CW

    Can Wang 1

  • XC

    Xiuwei Chen 1*

  • 1. Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, China

  • 2. Department of Gynecology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China

In the published article, there was an error in Figure 9 as published. Figure 9C in the published article showed the results of wound healing assays in ovarian cancer cell lines A2780 and SKOV3 after knockdown of ARRDC2. There was an error in Figure 9C in the published article, the image of wound healing in the ovarian cancer cell line SKOV3 at 0 h after knockdown of ARRDC2 was wrong. The corrected Figure 9 and its caption appear below.

FIGURE 9

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

arrestin domain containing 2, biomarker, immunity, prognosis, ovarian cancer

Citation

Zhang M, Liu Y, Liu Y, Hou S, Li H, Ma Y, Wang C and Chen X (2022) Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer. Front. Genet. 13:978493. doi: 10.3389/fgene.2022.978493

Received

26 June 2022

Accepted

25 July 2022

Published

24 August 2022

Volume

13 - 2022

Edited and reviewed by

Jared C. Roach, Institute for Systems Biology (ISB), United States

Updates

Copyright

*Correspondence: Xiuwei Chen,

This article was submitted to Human and Medical Genomics, a section of the journal Frontiers in Genetics

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics